Pharmacokinetic Profiling in Drug Research Bernard Testa 2006 John Wiley
▐ 自2024/1/1 00:00起,台灣樂天市場「屈臣氏」將不贈送 LINE POINTS 點數
▐ 自2023/2/1 00:00起,樂天Kobo電子書不贈送 LINE POINTS 點數,請會員多加留意。
▐ LINE POINT點數回饋依照樂天提供扣除折價券(優惠券)、與運費後之最終金額進行計算。
▐ 愛買與愛票網、a la sha(2023/8/1生效)、GAME休閒館(2023/8/1生效)、專品藥局(2023/8/1生效)等部分店家不參與全站加碼,請詳閱LINE Points 加碼店家清單:https://lin.ee/Y2CcVdk/rcfk
▐ 注意事項
(1)部分服務及店家不符合贈點資格,購買後將不贈送 LINE Points 點數,亦不得使用點數紅包,如:比漾廣場、神腦生活、MyCard、愛美麗福利社、展翔通訊、ezcook 美食廚房、葳豐數位商城、吉盈數位商城、森林巨人、包材中心、KABO佳麗寶家電批發、LuLuLu精品店、NewSTYLE新風尚潮流、0216零食會社、美寶家電、純米小鋪、LILY科技新櫃、登芳3C電子雜貨賣場、豐饌御鴨、鼎耀通訊、誠選3C、Smile、葳豐數位商城二店、米蘭寶、BoBo Outlet代購屋、楊家食品(2022/10/1生效)、樂天Kobo電子書(2023/2/1生效)、屈臣氏(2024/1/1生效)等,請詳閱LINE Points 加碼店家清單。
(2)需透過LINE購物前往台灣樂天市場,並在同一瀏覽器於24小時內結帳,才享有 LINE Points 回饋。
(3)若購買之訂單(包含預購商品)未符合樂天市場 45 天內完成訂單出貨及結帳,則不符合贈點資格。
(4)如使用App、或中途瀏覽比價網、回饋網、Google等其他網頁、或由網頁版(電腦版/手機版網頁)切換為App都將會造成追蹤中斷而無法進行 LINE Points 回饋。
(5) LINE 購物為購物資訊整合性平台,商品資料更新會有時間差,如顯示之商品規格、顏色、價位、贈品與台灣樂天市場銷售網頁不符,以銷售網頁標示為準。
(6)Pickup店家之有效訂單需於下單後40天內使用完畢才符合分潤條件
(7) 若上述或其他原因,致使消費者無接收到點數回饋或點數回饋有爭議,台灣樂天市場保有更改條款與法律追訴之權利,活動詳情以樂天市場網站公告為準。商品描述
【簡介】 Informatics and robotics are the workhorses of a technological revolution in drug research. On them are based combinatorial chemistry, which yields compounds by the many thousands, and high-throughput bioassays, which screen them for activity. The results are avalanches of 'hits', which invade the databases like swarms of locusts. But far from being a plague, these innumerable compounds become a blessing if properly screened for 'drugability', i.e., for 'drug-like' properties such as good pharmacokinetic (PK) behavior. Pharmacokinetic profiling of bioactive compounds has, thus, become a sine qua non condition for cherry-picking the most promising hits. Just as important, but less visible, are the structure-property and structure-ADME relations, which emerge from PK profiling and provide useful feedback when designing new synthetic series. As a result, the screening, design, and optimization of pharmacokinetic properties has become the bottleneck and a major challenge in drug research. To shorten the time-consuming development and high rate of attrition of active compounds ultimately doomed by hidden pharmacokinetic defects, powerful biological, physicochemical, and computational approaches are being developed, whose objectives are to increase the clinical relevance of drug design and to eliminate as soon as possible compounds with unfavorable physicochemical properties and pharmacokinetic profiles. The profiling of ADME properties (absorption, distribution, metabolism, and excretion) is the topic of this book. Following the extraordinary success of the previous work ('Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies', Eds. B. Testa, H. van de Waterbeemd, G. Volkers, R. Guy, Verlag Helvetica Chimica Acta, Zurich, 2001, 655 pages), there was a need for an essentially new edition focusing on the latest theoretical and technological breakthroughs. In this unique work, international authorities and practicing experts from academia and industry offer state-of-the-art presentations of concepts, methods and technologies now in use or development in drug research. The biological strategies emphasized in the book include cell cultures, drug-metabolizing enzymes, transporters and plasma protein binding. The physicochemical strategies focus on artificial membrane-permeability assays, on solubility and lipophilicity and related molecular properties as factors and predictors of pharmacokinetic behavior, and on stability and solid-state properties. Computational strategies comprize the exploration of property spaces, pharmacophore searching to predict biotransformation and enzyme inhibition, and expert systems to process biopharmaceutical profiling data. In addition to its 28 chapters, the book includes a CD-ROM containing the invited lectures, oral communications, and posters (in full version) presented at the Third LogP Symposium, 'Physicochemical and Biological Profiling in Drug Research', held at the Federal Institute of Technology (ETH) of Zurich in March 2004. 【目錄】